About Technology Issues FAQ

Links

Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial

Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.